Overview
Location
United States, California, San Francisco
Employees
11-50
Founded date
2002
Mentions in press and media 19
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 6, 2014 | Trevi Therapeutics gets $26M for opioid anti-itch drug | Trevi is focusing on two indications: Uremic pruritus and prurigo nodularis. The company will use the funding as it continues to enroll U.S. patients in its uremic pruritus trial, and will begin enrolling Europeans by the close of the year.... |
| Apr 15, 2014 | Rapid Micro Biosystems Closes Additional Funding | Rapid Micro Biosystems, a Bedford, MA-based provider of automated, non-destructive, rapid microbial detection for quality control testing of pharmaceutical and personal care products, closed on additional funding of undisclosed amount. Back... |
| Sep 24, 2013 | Mobile care coordination tool to improve patient safety raises $27M | PatientSafe Solutions received a strategic investment from strategic investment from EDBI, the investment arm of the Singapore Economic Development Board. Merck Global Health Innovation Fund led the round and Camden Partners, TPG Biotech, a... |
| Jun 29, 2013 | Rapid Micro Biosystems Raises $32.6M in Series B Financing | Rapid Micro Biosystems, a Bedford, MA-based provider of microbial detection for quality control testing within the pharmaceutical and personal care products market segments, raised $32.6m in Series B financing. The round was led by Longitud... |
| Mar 11, 2013 | Alphabet Energy Raises $16M in Series B Financing | Alphabet Energy Inc., a Hayward, Calif.-based developer of a platform silicon thermoelectric technology that generates power from a variety of waste-heat sources, raised $16m in Series B financing. The round was led by Encana Corp., with pa... |
| Jan 10, 2013 | Conventus Orthpaedics, Minnesota device startup treating wrist fractures, seeks $2 million | Conventus is led by Paul Hindrichs, a former St. Jude Medical executive, and investors in the company are Spray Venture Partners and TPG Biotech. [Photo Credit: Pile of Money from Big Stock Photo] Promoted This Patient Experience Checklist ... |
| Dec 18, 2012 | Trevi Therapeutics Closes $10M Series A Financing | Trevi Therapeutics, Inc., a New Haven, CT-based drug development company, has closed a $10m Series A financing. Backers include TPG Biotech, which had previously made a seed investment in the company to conduct pre-clinical testing, regulat... |
| Feb 2, 2012 | Auxogyn Closes Final Tranche of Series A Funding Round | Auxogyn Inc., a Menlo Park, Calif.-based company that focuses on products for women’s reproductive health, has closed a final tranche in its Series A financing. Investors in the round include Kleiner Perkins Caufield and Byers, TPG Biotech ... |
| Feb 2, 2012 | Auxogyn Completes $20M In Series A | MENLO PARK, CA, Company focused on advancing women's reproductive health announced the close of the final tranche of its Series A financing, bringing the total funding to $20 million. >> Click here for more funding data on Auxogyn ... |
Show more
Reviews 0
FAQ about TPG Biotech
When was TPG Biotech founded?
TPG Biotech was founded in 2002.
What has the press written about TPG Biotech?
Parsers VC has collected 19 articles mentioning TPG Biotech, among them “Trevi Therapeutics gets $26M for opioid anti-itch drug” (Nov 6, 2014) and “Rapid Micro Biosystems Closes Additional Funding” (Apr 15, 2014).
Is TPG Biotech still active?
TPG Biotech is probably closed: its latest activity on Parsers VC dates from Mar 4, 2015.